Hemosiderotic Fibrolipomatous Tumor.
暂无分享,去创建一个
[1] R. Sciot,et al. Angiomatoid fibrous histiocytoma – case series with emphasis on a late fibrotic variant , 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[2] E. Montgomery,et al. TGFBR3 and MGEA5 Rearrangements in Pleomorphic Hyalinizing Angiectatic Tumors and the Spectrum of Related Neoplasms , 2014, The American journal of surgical pathology.
[3] C. Fletcher. Recently characterized soft tissue tumors that bring biologic insight , 2014, Modern Pathology.
[4] C. Antonescu,et al. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor , 2011, Genes, chromosomes & cancer.
[5] P. Cin,et al. Hybrid Myxoinflammatory Fibroblastic Sarcoma/Hemosiderotic Fibrolipomatous Tumor: Report of a Case Providing Further Evidence for a Pathogenetic Link , 2010, The American journal of surgical pathology.
[6] R. Sciot,et al. Two genetic pathways, t(1;10) and amplification of 3p11–12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions , 2009, The Journal of pathology.
[7] A. Mansoor,et al. Cytogenetic analysis of a hemosiderotic fibrolipomatous tumor. , 2008, Cancer genetics and cytogenetics.
[8] C. Fletcher,et al. Haemosiderotic fibrolipomatous tumour (so‐called haemosiderotic fibrohistiocytic lipomatous tumour): analysis of 13 new cases in support of a distinct entity , 2006, Histopathology.
[9] J. Fanburg–Smith,et al. Hemosiderotic Fibrohistiocytic Lipomatous Lesion: Ten Cases of a Previously Undescribed Fatty Lesion of the Foot/ankle , 2000, Modern Pathology.